The Food and Drug Administration June 25 formally updated its patient and provider fact sheets for the Moderna and Pfizer COVID-19 vaccines to include warnings about the increased risk of heart inflammation in patients.

FDA also revised its safety recommendations for bronchoscope reprocessing. The agency now recommends health care facilities and staff consider sterilization over high-level disinfection when reprocessing. Other requests include not using damaged devices or those that have failed a leak test and performing preventive maintenance and proper inspection of bronchoscopes

Related News Articles

Headline
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee today by a unanimous vote recommended that the FDA issue an…
Headline
The AHA has received a $1 million grant from the Centers for Disease Control and Prevention to continue for one year its efforts to encourage COVID-19…
Headline
The Food and Drug Administration yesterday released an updated enforcement policy related to face masks, barrier face coverings, face shields,…
Headline
The Centers for Disease Control and Prevention Friday updated its guidance for health care personnel on preventing and controlling infections during the COVID-…
Headline
According to new Centers for Disease Control and Prevention research, hospitalization for COVID-19 for children and adolescents increased four-fold in August…
Headline
The Centers for Disease Control and Prevention yesterday alerted health care providers and the public to reports of severe illness associated with using…